June 15, 2017
BIOPHYTIS selects SGS Life Science Services to conduct MACA-PK, clinical study of Macuneos in dry AMD. Read the Press Release
BIOPHYTIS selects SGS Life Science Services to conduct MACA-PK, clinical study of Macuneos in dry AMD. Read the Press Release
Participation of Biophytis to Bio€quity Europe 2017. May 22-23, 2017. Marriott Rive Gauche, Paris, France
Biophytis announces the issuance of a €3 million tranche of ORNANEBSA. Read the Press Release
First patient-in in the United States and opening of 2 clinical centers for the SARA-OBS study on Sarcopenia. Read the Press Release
The SARA clinical program – Towards a first treatment for Sarcopenia. Interviews conducted during ICSFR 2017. Watch the video
BIOPHYTIS confirms that Sarconeos modulates the Renin-Angiotensin System and activates muscular metabolism in the SARA-PK clinical trial. Read the Press Release
Biophytis secures funding for phase 2B clinical trial in Sarcopenia, SARA-INT. Read the Press Release
Biophytis opens the first clinical centers in Europe and starts the recruitment of sarcopenic patients for SARA-OBS study. Read the Press Release
Biophytis to present four scientific studies at the International Conference on Frailty & Sarcopenia Research (ICFSR) in Barcelona. Read the Press Release